Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Melanoma × Ipilimumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 113 INDUSTRY 82 NIH 13 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrent Squamous Cell Lung Carcinoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Advanced Solid Tumors 1

Interventions

Interferon-alpha 6 Radiosurgery 4 Dacarbazine 4 aldesleukin 3 Gene Expression Profiling 3 Filgrastim 3 Cisplatin 3 encorafenib 2 binimetinib 2 Vinblastine 2 Temozolomide 2 Radiotherapy 2 Immunologic Techniques 2 Immunohistochemistry 2 trametinib 1 sulforaphane 1 romidepsin 1 perifosine 1 pembrolizumab 1 peginterferon alfa-2b 1 lorukafusp alfa 1 dabrafenib 1 alvocidib 1 alovudine 1 X-Rays 1 Watchful Waiting 1 Vinorelbine 1 Thrombopoietin 1 Thalidomide 1 Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03235245 2025-08-01

EBIN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡